Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer metadata updated to Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T20:39:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    A new version (v3.3.2) was added on 2025-11-21 with an updated Study Status. The previous revision (v3.2.0) was removed on 2025-08-28.
    Difference
    0.3%
    Check dated 2025-11-25T10:24:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding lapse notice warning about potential delays and operating status has been removed from the page. This is a non-critical site-wide notice change and does not alter the trial record details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:46:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Version history was updated to include changes to Study Status, Contacts/Locations, and Study Design, with the latest update posted on 2025-08-28.
    Difference
    0.1%
    Check dated 2025-11-03T20:37:48.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    9%
    Check dated 2025-10-06T04:44:57.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T01:34:14.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.